NERV · Insider trading · 13F holders · Congress trades
Minerva Neurosciences Inc (NERV)
Who is buying and selling NERV: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 9
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
NERV at a glance
- No open-market insider purchases or sales of NERV were filed in the last 90 days.
- 9 13F filers hold NERV among their 50 largest positions, worth $96.1M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (15.6%), Acuta Capital Partners, LLC (2.7%) and Vivo Capital, LLC (2.2%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in NERV.
NERV insider trading
No open-market insider purchases or sales of NERV were filed in the last 90 days.
Who owns NERV? Hedge funds and superinvestors
9 13F filers hold NERV among their 50 largest positions, worth $96.1M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (15.6%), Acuta Capital Partners, LLC (2.7%) and Vivo Capital, LLC (2.2%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Vivo Capital, LLCHedge fund | 2.2% | $24.0M | 4,322,747 | +0.0% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 0.8% | $18.3M | 3,288,777 | +2.3% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 15.6% | $12.1M | 2,175,802 | +31.4% shares | Q2 2026 |
| Foresite Capital Management VI LLCHedge fund | 1.7% | $11.0M | 1,985,584 | -0.1% shares | Q2 2026 |
| Spruce Street Capital LPHedge fund | 1.8% | $9.2M | 1,655,500 | +0.0% shares | Q2 2026 |
| Trails Edge Capital Partners, LPHedge fund | 1.3% | $7.9M | 1,419,000 | +0.0% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 0.9% | $5.6M | 1,001,373 | +303.0% shares | Q2 2026 |
| Dv Equities, LLCInvestment manager | 0.6% | $4.2M | 754,397 | — | Q2 2026 |
| Acuta Capital Partners, LLCHedge fund | 2.7% | $3.9M | 709,500 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 9). Screen NERV in the grand portfolio →
NERV stock trades by members of Congress
No member of Congress has disclosed a trade in NERV.
NERV questions and answers
Are insiders buying NERV stock?
No open-market insider purchases or sales of NERV were filed in the last 90 days.
Which hedge funds own NERV?
9 13F filers hold NERV among their 50 largest positions, worth $96.1M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (15.6%), Acuta Capital Partners, LLC (2.7%) and Vivo Capital, LLC (2.2%). In their latest 13Fs, 0 managers opened a new position and 2 added to one.
Has Congress traded NERV?
No member of Congress has disclosed a trade in NERV.
Who is the largest holder of NERV?
Among 13F filers, Vivo Capital, LLC reports the largest NERV position, $24.0M (4,322,747 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Ally Bridge Group (NY) LLC's: 15.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.